Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Gil

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution's experienceJoaquim Bosch-Barrera, Carlos García-Franco, Francisco Guillén-Grima, et al.
Cancer Research|November 17, 2006
Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibodyJonathan Perk, Ignacio Gil-Bazo, Yvette Chin, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world dataAna D Ramos-Guerra, Benito Farina, Jaime Rubio Pérez, et al.
Neuro-Oncology|October 14, 2011
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosisDolores Subirá, Cristina Serrano, Susana Castañón, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Liquid biopsies in lung cancer: the new ambrosia of researchersChristian Rolfo, Marta Castiglia, David Hong, et al.
Surgical Oncology|September 2, 2020
Ultrasound staging in breast cancer: A decision-making oriented approach to axillary metastatic burden predictionMaría Martínez Gálvez, José Aguilar Jiménez, José Ignacio Gil Izquierdo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2005
Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancerIgnasio Gil-Bazo, Ignacio Gil Bazo, Victoria Catalán Goni, et al.
Surgical Oncology|July 24, 2021
Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive resultsDiego Flores-Funes, José Aguilar-Jiménez, María Martínez-Gálvez, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution's experienceJoaquim Bosch-Barrera, Carlos García-Franco, Francisco Guillén-Grima, et al.
Cancer Research|November 17, 2006
Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibodyJonathan Perk, Ignacio Gil-Bazo, Yvette Chin, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world dataAna D Ramos-Guerra, Benito Farina, Jaime Rubio Pérez, et al.
Neuro-Oncology|October 14, 2011
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosisDolores Subirá, Cristina Serrano, Susana Castañón, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Liquid biopsies in lung cancer: the new ambrosia of researchersChristian Rolfo, Marta Castiglia, David Hong, et al.
Surgical Oncology|September 2, 2020
Ultrasound staging in breast cancer: A decision-making oriented approach to axillary metastatic burden predictionMaría Martínez Gálvez, José Aguilar Jiménez, José Ignacio Gil Izquierdo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2005
Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancerIgnasio Gil-Bazo, Ignacio Gil Bazo, Victoria Catalán Goni, et al.
Surgical Oncology|July 24, 2021
Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive resultsDiego Flores-Funes, José Aguilar-Jiménez, María Martínez-Gálvez, et al.
Pageof 15